Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland.

Samuli Kangaslampi, Aino Hausen, Tarina Rauteenmaa

Journal of Psychoactive Drugs January 1, 2020 DOI: 10.1080/02791072.2020.1767321 (opens in new tab) via PubMed

Summary

AI-generated from the abstract

Some people report lasting positive changes in life satisfaction, well-being, or mental health after taking psychedelic drugs, possibly because these substances can trigger mystical-type experiences. A study of 288 people who completed a Finnish translation of the Revised Mystical Experiences Questionnaire (MEQ30) about their first psychedelic use found the questionnaire to be reliable and valid. A four-factor structure—mystical qualities, positive mood, transcendence, and ineffability—fit the data best. Higher MEQ30 scores and full mystical experiences were strongly linked to describing the experience as mystical, spiritual, or religious and as personally significant, and were somewhat linked to sadness or difficulty. Mystical experiences were especially tied to positive changes in relationships with nature and oneself and in creativity, and were more common with larger doses.

Study at a glance

Characteristics Cross-sectional survey Peer reviewed
Sample size 288
Population People retrospectively reporting on their first time using a psychedelic
Topics LSD Mystical experience Psilocybin
Keywords Psychedelics Well-being
Key finding The Finnish MEQ30 shows internal consistency reliability and preliminary evidence for criterion and discriminant validity, with a four-factor structure fitting best; mystical experiences were associated with positive changes in relationships with nature and oneself and in creativity, and were more common with larger doses.

Abstract

Despite their acutely inebriating and sometimes unpleasant effects, some people report positive changes in life satisfaction, well-being, or mental health after taking psychedelic drugs. One explanation may be the ability of psychedelics to trigger mystical-type experiences. We examined the validity, reliability, and factor structure of a novel Finnish translation of the Revised Mystical Experiences Questionnaire (MEQ30) among 288 people retrospectively reporting on their first time using a psychedelic. We found evidence for internal consistency reliability and preliminary evidence for criterion and discriminant validity of the Finnish MEQ30. A four-factor structure with factors for mystical qualities, positive mood, transcendence, and ineffability had the best, fair to reasonable fit to the data. MEQ30 scores and having a full mystical experience were highly associated with describing the experience as mystical, spiritual, or religious, and as personally significant, and somewhat associated with the experience being sad or difficult. Mystical experiences were especially associated with positive changes in relationships with nature and oneself and in creativity. Mystical experiences were more common with larger doses. Increasing research suggests mystical-type experiences to relate to positive changes after taking psychedelics. The Finnish MEQ30 is able to tap into relevant information about this aspect of people's psychedelic experiences.

Explore topics

Comments

No comments yet.

Log in to comment